455 — Tianda Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Tianda Pharmaceuticals, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2022 March 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	9 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	349	343	162	85.7	64.8
Net Total Accounts Receivable
Net Total Receivables	145	143	106	81.4	79.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	577	558	344	216	198
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	436	401	413	387	385
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	1,164	1,088	917	765	748
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	272	362	313	251	238
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	407	461	325	259	291
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	757	628	592	506	457
Total Liabilities & Shareholders' Equity	1,164	1,088	917	765	748
Total Common Shares Outstanding